Shabbir Ansari: Rare F3 Missense Variants Markedly Impair Coagulation Initiation
Shabbir Ansari, Assistant Professor at University of Texas at Tyler School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Blood:
“Excited to share that our new paper in Blood is online!
We demonstrate that selected rare human F3 (tissue factor) missense variants markedly impair coagulation initiation via two distinct mechanisms: disruption of TF–FVIIa binding, or perturbation of a TF exosite required for efficient macromolecular substrate activation (Factors IX and X). Although these variants do not alter standard clinical coagulation assays, carriers exhibit reduced basal coagulation activation in vivo, supporting a previously unappreciated role for TF in supporting basal FVII activation in humans.
As an added bonus, one of the images from this study was selected for the journal’s cover image, recognizing the conceptual and mechanistic insights from this work. Many thanks to my postdoc mentor, Sol Schulman, co-authors, and collaborators for a fantastic team effort.”
Title: Human missense variants in F3 impair the initiation of blood coagulation
Authors: Shabbir A. Ansari, Marisa A. Brake, Nishtha Pathak, James T. Flaumenhaft, Jacob G. Ludington, Natasha Panwar, Ernest Turro, Sol Schulman
Read the Full Article on Blood
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 7, 2026, 15:29Rowan Paul: MSCs Show Strongest Pain Reduction in Regenerative Medicine Approaches
-
Feb 7, 2026, 15:24Abeer Alanazi: Asundexian Reduces Stroke and Mortality Without Increased Bleeding
-
Feb 7, 2026, 15:13Caitlin Raymond: Understanding Risks in Rare Group A Subtypes with Anti-A1 Antibodies in Transfusion Medicine
-
Feb 7, 2026, 14:57Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
-
Feb 7, 2026, 14:32Ming Y Lim: Launching a Virtual Iron Deficiency Clinic at the University of Utah School of Medicine
-
Feb 7, 2026, 14:30Exploring Thrombin Generation Profiling in Rare Coagulation Factor Deficiencies – JTH
-
Feb 7, 2026, 14:25C Michael Gibson: Asundexian Reduces Ischemic Stroke Without Increasing Bleeding Risk
-
Feb 7, 2026, 14:23Marco Antonio Ramírez Rodríguez: Endovascular Management of Pelvic Venous Hypertension in May–Thurner Syndrome
-
Feb 7, 2026, 14:19Martin Haluzík Analyzes the Overall Accuracy of Current Available Smartwatches in Identifying AF